Behcet's disease and joint affection


如何引用文章

全文:

详细

Aim. To study joint pathology in patients with Behcet's disease (BD). Material and methods. The trial enrolled 183 BD patients (128 males, 54 females, mean age 32,0 ± 9.8 years, age at BD onset 22.3 ± 9.9 years, mean duration of the disease 9.5 ± 8.9 years. Results. Joint pathology occurred in 74.8% patients, in 10.9% patients the disease onset was associated with arthritis and arthralgia. 3 patients had aceptic necrosis of the head of the femur and knee joint, 3 patients - bone marrow infarction. Knee joints were affected more frequently than others (up to 40%) followed by ankle, elbow and radiocarpal and other joints. In BD duration about 10 years, none of the examinees had stage III of sacroiliitis, stage II was diagnosed only in 4 patients, stage I (suspicion) - in 9. Significant sacroillitis was not registered, bilateral sacroillitis occurred only in 9 patients. HLA B5 was detected in 61% patients while HLA B27 - only in 9.7%. Conclusion. The articular syndrome was seen in 3/4 of BD patients. Arthritis runs a recurrent course. Erosive arthritis, sacroillitis and combination of the latter with HLA B27 are rare.

作者简介

Z Alekberova

ГУ Институт ревматологии РАМН, Москва

A Elonakov

ГУ Институт ревматологии РАМН, Москва

R Goloeva

ГУ Институт ревматологии РАМН, Москва

A Smirnov

ГУ Институт ревматологии РАМН, Москва

I Guseva

ГУ Институт ревматологии РАМН, Москва

E Nasonov

ГУ Институт ревматологии РАМН, Москва

参考

  1. Pipitone N., Boiardi L., Olivieri I. et al. Clinical manifestation of Behcet's disease: an analysis of 2147 patients. Med. J. Yonsei 1997; 38: 423-427.
  2. Kim H., Choi K., Song Y. Arthropathy in Behcet's disease. Scand. J. Rheumatol. 1997; 26: 125-129.
  3. Benamour S., Leroual В., Alaoui F. Joint manifestation in Behcet's disease. A review of 340 casese. Rev. Rheum. Engl. Ed. 1998; 65: 299-307.
  4. Krause I., Mader R., Sulkes J. et al. Behcet's disease in Israel: the influence of ethnic origin or disease expression and severity. J. Rheumatol. 2001; 28: 1033-1036.
  5. de-Aboosi M., al-Salen A. et al. Behcet's disease: clinical study of Jordanian patients. Int. J. Dermatol. 1996; 35: 623-625.
  6. International Study Group for Behcet's Disease: Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078-1080.
  7. Yurdakul S., Yazici H., Tuzun Y. et al. The arthritis of Behcet's disease: a prospective study. Ann. Rheum. Dis. 1983; 42: 505-575.
  8. Dilsen N., Komce M., Aral O. Why Behcet's disease should be accepted as a seronegative arthritis. In: Recent advances in Behcet's disease. London: Royal Society of Medicine Services; 1986. 281-284.
  9. Chang H. K., Lee D., Yung S. et al. The comparison between Behcet's disease and spondyloarthritides: Does Behcet's disease belong to the spondiloarthropathy complex. J. Korean Med. Sci. 2002; 17: 524-529.
  10. Moll J., Haslock I., Macral I. et al. Associations between ankylosing spondilitis, psoriatic arthritis, Reiter's disease, the intestinal arthropaties, and Behcet's syndrome. Medicine (Baltimore) 1974; 53: 343-367.
  11. Yazici H., Tuzlaci M., Yurdakul S. A controlled survey of sacroillitis in Behcet's disease. Ann. Rheum. Dis. 1981; 40: 558-559.
  12. Gur A., Sarac A., Barkan Y. et al. Arthropathy, quality of life, depression, and anxiety in Behcet's disease relationship between arthritis and these factors. Clin. Rheumatol. 2006; 25 (4): 524-531.
  13. Lehner Т., Batchelor Y. Classification and an immunogenetic basic of Behcet's syndrome. In: Lehner Т., Barns C., eds. Behcet's syndrome. New York: Academic Press; 1979. 13-32.

版权所有 © Consilium Medicum, 2008

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 
 


##common.cookie##